Prostate MRI: Who, when, and how? Report from a UK consensus meeting

Clinical Radiology

Volumn 68, Issue 10, 2013, Pages 1016-1023

  Kirkham, A P S ^a   Haslam, P ^b   Keanie, J Y ^c   McCafferty, I ^d   Padhani, A R ^e   Punwani, S ^a   Richenberg, J ^f   Rottenberg, G ^g   Sohaib, A ^h   Thompson, P ^g   Turnbull, L W ⁱ   Kurban, L ^j   Sahdev, A ^k   Clements, R ^l   Carey, B M ^m   Allen, C ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e MOUNT VERNON CANCER CENTRE   (United Kingdom)

^f ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^g GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^h ROYAL MARSDEN HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF HULL   (United Kingdom)

^j ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^k BARTS HEALTH NHS TRUST   (United Kingdom)

^l ROYAL GWENT HOSPITAL   (United Kingdom)

^m ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CANCER STAGING; CLINICAL PRACTICE; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RADIODIAGNOSIS; RADIOLOGIST; UNITED KINGDOM;

BIOPSY; CONTRAST MEDIA; GREAT BRITAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 84883454944     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2013.03.030     Document Type: Article

References (59)

1. D. Ilic, D. O'Connor, and S. Green Screening for prostate cancer: an updated Cochrane systematic review BJU International 107 2011 882 891
2. A. Ouzzane, P. Puech, and L. Lemaitre Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading Urology 78 2011 1356 1362
3. L. Dickinson, H.U. Ahmed, and C. Allen Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting Eur Urol 59 2011 477 494
4. J.O. Barentsz, J. Richenberg, and R. Clements ESUR prostate MR guidelines 2012 Eur Radiol 22 2012 746 757
5. C. Parker, D. Muston, and J. Melia A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival Br J Cancer 94 2006 1361 1368
6. H.U. Ahmed, M. Arya, and A. Freeman Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol 13 2012 e509 e517
7. T. Wolters, M.J. Roobol, and P.J. van Leeuwen A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial J Urol 185 2011 121 125
8. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer New Engl J Med 367 2012 203 213
9. P. Puech, E. Potiron, and L. Lemaitre Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens Urology 74 2009 1094 1099
10. A.B. Rosenkrantz, S. Mendrinos, and J.S. Babb Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected J Urol 187 2012 2032 2038
11. A. Villers, P. Puech, and D. Mouton Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings J Urol 176 2006 2432 2437
12. A. Tanimoto, J. Nakashima, and H. Kohno Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging J Magn Reson Imaging 25 2007 146 152
13. G.M. Villeirs, G.O. De Meerleer, and P.J. De Visschere Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients Eur J Radiol 77 2011 340 345
14. N. Girouin, F. Mège-Lechevallier, and A. Tonina Senes Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 17 2007 1498 1509
15. A.E. Wefer, H. Hricak, and D.B. Vigneron Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 164 2000 400 404
16. H.U. Ahmed, A. Kirkham, and M. Arya Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 6 2009 197 206
17. E. Lecornet, H.U. Ahmed, and Y. Hu The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation J Urol 188 2012 974 980
18. B. Rocco, O. de Cobelli, and M.E. Leon Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report Eur Urol 49 2006 827 833
19. T. Hambrock, D.M. Somford, and C. Hoeks Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen J Urol 183 2010 520 527
20. J. Haffner, L. Lemaitre, and P. Puech Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection BJU Int 108 2011 E171 E178
21. T. Hambrock, C. Hoeks, and C. Hulsbergen-van de Kaa Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort Eur Urol 61 2012 177 184
22. C.M. Moore, N.L. Robertson, and N. Arsanious Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review Eur Urol 63 2013 125 140
23. N. Lawrentschuk, and N. Fleshner The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels BJU Int 103 2009 730 733
24. D. Margel, S.A. Yap, and N. Lawrentschuk Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study J Urol 187 2012 1247 1252
25. H.A. Vargas, O. Akin, and A. Afaq Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer J Urol 188 2012 1732 1738
26. M.S. Borofsky, A.B. Rosenkrantz, and N. Abraham Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy? Urology 2013 Feb 7 10.1016/j.urology.2012. 12.026 pii: S0090-4295(12)01570-1
27. Prostate cancer: diagnosis and treatment 2008 National Institute for Health and Clinical Excellence London Available at: http://www.nice.org.uk/cg58 [accessed 4 February 2013]
28. L. Wang, H. Hricak, and M.W. Kattan Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms Radiology 238 2006 597 603
29. L. Wang, H. Hricak, and M.W. Kattan Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram Radiology 242 2007 182 188
30. C.M. Hoeks, J.O. Barentsz, and T. Hambrock Prostate cancer: multiparametric MR imaging for detection, localization, and staging Radiology 261 2011 46 66
31. F. Cornud, M. Rouanne, and F. Beuvon Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5 Tesla: should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria? Eur J Radiol 81 2012 e591 e597
32. A.S. Duffield, T.K. Lee, and H. Miyamoto Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2009 2274 2278
33. A. Qayyum, F.V. Coakley, and Y. Lu Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging AJR Am J Roentgenol 183 2004 1079 1083
34. T. Tamada, T. Sone, and Y. Jo Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis Radiology 248 2008 531 539
35. S. White, H. Hricak, and R. Forstner Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images Radiology 195 1995 385 390
36. D. Cornfeld, and J. Weinreb MR imaging of the prostate: 1.5 T versus 3 T Magn Reson Imaging Clin N Am 15 3 2007 Aug 1 433 448
37. S.W.T.P.J. Heijmink, J.J. Fütterer, and T. Hambrock Prostate cancer: body-array versus endorectal coil MR imaging at 3 T - comparison of image quality, localization, and staging performance Radiology 244 2007 184 195
38. B.K. Park, H.M. Lee, and C.K. Kim Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy Invest Radiol 43 2008 789 793
39. J. Iwazawa, T. Mitani, and S. Sassa Prostate cancer detection with magnetic resonance imaging: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging? Diagn Interv Radiol 17 2011 243 248
40. P. Puech, N. Betrouni, and N. Makni Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results Int J Comput Assist Radiol Surg 4 2009 1 10
41. Y.S. Sung, H.J. Kwon, and B.W. Park Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps AJR Am J Roentgenol 197 2011 1122 1129
42. Y. Peng, Y. Jiang, and C. Yang Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score - a computer-aided diagnosis development study Radiology 2013 Feb 7
43. O. Rouvière MR assessment of recurrent prostate cancer after radiation therapy Radiology 242 2007 635 636 author reply 6-7
44. E. Casciani, E. Polettini, and E. Carmenini Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy AJR Am J Roentgenol 190 2008 1187 1192
45. C. Kim, B. Park, and H. Lee MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer AJR Am J Roentgenol 190 2008 1180 1186
46. D.V. Makarov, B.J. Trock, and E.B. Humphreys Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005 Urology 69 2007 1095 1101
47. A. Briganti, N. Suardi, and P. Capogrosso Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum Prostate 72 2012 186 192
48. S. Haukaas, J. Roervik, and O.J. Halvorsen When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer? Br J Urol 79 1997 770 776
49. J.C. Weinreb, J.D. Blume, and F.V. Coakley Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy - results of ACRIN prospective multi-institutional clinicopathologic study Radiology 251 2009 122 133
50. T. Kobus, T. Hambrock, and C.A. Hulsbergen-van de Kaa In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil Eur Urol 60 2011 1074 1080
51. Y. Mazaheri, A. Shukla-Dave, and H. Hricak Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging - correlation with pathologic findings Radiology 246 2008 480 488
52. L. Wang, Y. Mazaheri, and J. Zhang Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy Radiology 246 2008 168 176
53. R. Nagarajan, D. Margolis, and S. Raman MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores J Magn Reson Imaging 36 2012 697 703
54. C. Balleyguier, S. Ayadi, and K. Van Nguyen BIRADS classification in mammography Eur J Radiol 61 2007 192 194
55. D. Portalez, P. Mozer, and F. Cornud Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients Eur Urol 62 2012 986 996
56. B. Turkbey, H. Mani, and V. Shah Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds J Urol 186 2011 1818 1824
57. P. Bastian, B. Carter, and A. Bjartell Insignificant prostate cancer and active surveillance: from definition to clinical implications Eur Urol 55 2009 1321 1332
58. S.Y. Song, S.R. Kim, and G. Ahn Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients Prostate Cancer Prostatic Dis 6 2003 143 147
59. R. Mizuno, J. Nakashima, and M. Mukai Maximum tumor diameter is a simple and valuable index associated with the local extent of disease in clinically localized prostate cancer Int J Urol 13 2006 951 955